Prestige Consumer (NYSE: PBH) awards 2,981 RSUs to director Clark
Rhea-AI Filing Summary
Prestige Consumer Healthcare Inc. reported that director Celeste A. Clark acquired an equity award of 2,981 restricted stock units, valued at $155,000 based on a $52.00 closing share price on August 4, 2026, under the director compensation program. The units vest on the first anniversary of grant and will be settled in one share of common stock per vested unit upon the earliest of Clark’s death, separation, or a change in control. Following this award, 16,511 shares of common stock are reported as directly owned.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,981 shares
Net Buy
1 txn
Insider
Clark Celeste A.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, par value $0.01 per share F1 | 2,981 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock, par value $0.01 per share — 16,511 shares (Direct)
Footnotes (1)
- F1. The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.
Key Figures
RSU grant size: 2,981 units
Grant value: $155,000
Closing stock price: $52.00 per share
+1 more
4 metrics
RSU grant size
2,981 units
Restricted stock units granted to director on August 4, 2026
Grant value
$155,000
Value used to calculate number of restricted stock units
Closing stock price
$52.00 per share
Closing share price on August 4, 2026 used in RSU calculation
Shares owned after grant
16,511 shares
Total common shares reported as directly owned following the transaction
Key Terms
restricted stock units, director compensation program, change in control
3 terms
restricted stock units financial
"received 2,981 restricted stock units equal to $155,000 divided by the closing"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
director compensation program financial
"on August 4, 2026, in connection with the Issuer's director compensation program"
change in control regulatory
"promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Prestige Consumer Healthcare (PBH) report for Celeste A. Clark?
Prestige Consumer Healthcare reported that director Celeste A. Clark received 2,981 restricted stock units as part of its director compensation program. The equity award is valued at $155,000, based on a $52.00 closing stock price on August 4, 2026, and vests after one year.
How was the size of Celeste A. Clark’s PBH equity award determined?
The award size was calculated by dividing $155,000 by Prestige Consumer Healthcare’s $52.00 closing stock price on August 4, 2026, resulting in 2,981 restricted stock units. This ties the director’s compensation value directly to the company’s share price on the grant date.
When do Celeste A. Clark’s PBH restricted stock units vest and settle?
The 2,981 restricted stock units granted to Celeste A. Clark vest on the first anniversary of the grant date. They will be settled in one share of common stock per vested unit shortly after the earliest of her death, separation from service, or a change in control.
Was Celeste A. Clark’s PBH transaction an open-market buy or a compensation award?
The transaction was a compensation-related equity award, not an open-market purchase. Clark received 2,981 restricted stock units at a stated value of $155,000 under Prestige Consumer Healthcare’s director compensation program, with no cash price paid per unit by her.